HPC, Cord Blood

BIOLOGICAL2 trials

Sponsors

National Marrow Donor Program, BHI Therapeutic Sciences

Conditions

Acute Ischemic StrokeLeukemiaLymphomaMyelodysplastic Syndromes

Phase 1

Evaluation of the Safety and Efficacy of Hemacord HPC, Cord Blood in Subjects With Acute Ischemic Stroke

BHI Therapeutic SciencesAcute Ischemic Stroke

Start: 2021-03-06End: 2022-07-31Target: 10Updated: 2020-12-01

Phase 2

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

CompletedNCT00737516

National Marrow Donor ProgramLeukemia, Lymphoma, Myelodysplastic Syndromes

Start: 2000-01-31End: 2011-10-31Updated: 2013-06-21